MalariaMalaria is a tropical disease that also occurs in many temperate regions. It exacts a heavy toll of illness and death - especially among children and pregnant women. It also poses a risk to travellers and immigrants, with imported cases increasing in non-endemic areas. Treatment and control have become more difficult with the spread of drug-resistant strains of parasites and insecticide-resistant strains of mosquitoes that carry the parasites. TDR has supported research on this disease for many years, searching for new chemicals effective against the parasites, developing new drugs to treat the disease, identifying ways to prevent mosquitoes from transmitting the parasite, analyzing rapid diagnostic tests, and gathering evidence for the best ways to use the treatments in the harsh field conditions where malaria is endemic. Currently, our work is being conducted in the following areas: Evidence for antimalarial policy and access Innovative vector control interventions Accessible quality-assured diagnostics Integrated community-based interventions Lead discovery for drugs for infectious tropical diseases Latest News
6 November 2009 African Malaria Research Initiative Moves to CameroonLocation expands opportunities for central African and French-speaking scientists.
6 November 2009 Genetically modified mosquito preparations reviewed at MIM meetingNeed to develop principles for safety and efficacy testing
5 November 2009 Managing drug and insecticide resistance discussion at MIM meeting
4 November 2009 Malaria eradication requires new toolsFocus of today's discussion at MIM conference in Nairobi
24 April 2009 Evaluation of malaria diagnostics tests by WHO and partners finds variation in test performanceWHO/TDR/FIND study Rectal artesunate and severe malariaRead about a placebo-controlled trial of pre-referral rectal artesunate to prevent death and disability in severe malaria. Published online in The Lancet, 8 December 2008 DOI:10.1016/S0140-6736(08)61734-1. |
|
